Bal Pharma Share Price

86.83-0.97 (-1.10%)

Closed
As On: 19 Jun, 2026, 03:40 PM IST
As On: 19 Jun, 2026, 03:40 PM IST

Sector: Pharmaceuticals
Industry: Pharma - Indian

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Open	87.85
High	89.80
Low	86.11
Prev Close	87.79
Volume	19,150
VWAP(₹)	88.15

Share Price	Value
Today/Current/Last	86.8387.00
Previous Day	87.7988.84

Bal Pharma Share Recommendations

Recent Recos

Target₹116
OrganizationNirmal Bang Securities
BUY

View all Stock Recommendations

News & Analysis

View all Bal Pharma Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

Income (P&L)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	83.84	88.02	75.14	66.59	82.96
Total Income Growth (%)	-4.75	17.13	12.84	-19.73	12.62
Total Expenses	76.57	81.37	70.57	62.33	76.42
Total Expenses Growth (%)	-5.91	15.32	13.21	-18.43	12.24
EBIT	7.27	6.64	4.58	4.26	6.54
EBIT Growth (%)	9.51	45.16	7.35	-34.86	17.27
Profit after Tax (PAT)	3.59	1.78	0.71	0.20	5.43
PAT Growth (%)	101.89	150.83	253.74	-96.31	1,029.22
EBIT Margin (%)	8.67	7.55	6.09	6.40	7.89
Net Profit Margin (%)	4.29	2.02	0.94	0.30	6.55
Basic EPS (₹)	2.26	1.12	0.45	0.13	3.40

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	83.70	87.84	74.88	66.38	82.77
Total Income Growth (%)	-4.71	17.30	12.82	-19.81	12.31
Total Expenses	76.33	81.04	70.25	62.00	76.02
Total Expenses Growth (%)	-5.81	15.37	13.30	-18.44	12.64
EBIT	7.37	6.80	4.64	4.38	6.75
EBIT Growth (%)	8.40	46.52	6.01	-35.23	8.65
Profit after Tax (PAT)	3.70	1.95	0.78	0.32	5.61
PAT Growth (%)	90.10	149.05	141.73	-94.23	385.11
EBIT Margin (%)	8.80	7.74	6.19	6.59	8.16
Net Profit Margin (%)	4.42	2.22	1.04	0.49	6.77
Basic EPS (₹)	2.60	1.22	0.49	0.20	3.51

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	313.59	305.29	342.07	305.16	286.37
Total Revenue Growth (%)	2.72	-10.75	12.10	6.56	13.79
Total Expenses	307.65	300.15	333.02	300.41	277.18
Total Expenses Growth (%)	2.50	-9.87	10.86	8.38	11.96
Profit after Tax (PAT)	6.32	7.22	7.39	2.57	5.61
PAT Growth (%)	-12.38	-2.39	187.44	-54.17	18.33
Operating Profit Margin (%)	7.30	7.25	7.16	5.56	6.96
Net Profit Margin (%)	2.02	2.38	2.17	0.84	1.99
Basic EPS (₹)	3.95	4.54	4.94	1.67	3.79

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	312.80	304.65	341.89	305.25	286.86
Total Revenue Growth (%)	2.68	-10.89	12.00	6.41	13.83
Total Expenses	306.43	298.91	329.79	296.70	274.80
Total Expenses Growth (%)	2.52	-9.36	11.15	7.97	13.46
Profit after Tax (PAT)	6.75	7.80	10.27	6.13	8.58
PAT Growth (%)	-13.44	-24.07	67.68	-28.59	-5.70
Operating Profit Margin (%)	7.45	7.46	8.07	6.83	8.00
Net Profit Margin (%)	2.17	2.57	3.03	2.02	3.05
Basic EPS (₹)	4.27	4.89	6.72	3.90	5.79

All figures in Rs Cr, unless mentioned otherwise

Insights

Employee & Interest Expense
Company has spent 5.4% of its operating revenues towards interest expenses and 21.33% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

View Details

Balance Sheet

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	375.54	335.69	319.53	313.17	260.53
Total Assets Growth (%)	11.87	5.06	2.03	20.20	8.52
Total Liabilities	293.29	258.29	250.26	249.47	202.04
Total Liabilities Growth (%)	13.55	3.21	0.32	23.48	8.20
Total Equity	82.25	77.40	69.26	63.70	58.49
Total Equity Growth (%)	6.26	11.76	8.73	8.91	9.63
Current Ratio (x)	1.05	1.07	1.15	1.09	1.11
Total Debt to Equity (x)	1.94	1.94	2.01	2.05	1.67
Contingent Liabilities	0.00	17.10	16.96	-	-

Annual	FY 2026	FY 2025	FY 2025	FY 2024	FY 2023
Total Assets	391.06	289.61	350.56	361.30	347.70
Total Assets Growth (%)	11.55	10.73	-2.97	3.91	20.06
Total Liabilities	286.96	202.29	251.74	255.72	251.67
Total Liabilities Growth (%)	13.99	11.01	-1.56	1.61	24.41
Total Equity	104.10	87.32	98.82	105.58	96.03
Total Equity Growth (%)	5.34	10.09	-6.40	9.94	9.97
Current Ratio (x)	1.13	1.34	1.16	1.34	1.27
Total Debt to Equity (x)	1.48	1.12	1.46	1.27	1.30
Contingent Liabilities	0.00	16.25	17.10	16.96	16.44

All figures in Rs Cr, unless mentioned otherwise

View Details

Cash Flows

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	7.87	20.32	22.81	-1.84	27.71
Net Cash used in Investing Activities	-9.85	-14.92	-18.89	-22.18	-9.48
Net Cash flow from Financing Activities	-27.32	-7.84	-1.21	24.40	-18.13
Net Cash Flow	-29.31	-2.44	2.71	0.37	0.09
Closing Cash & Cash Equivalent	-46.12	1.75	4.20	1.49	1.11
Closing Cash & Cash Equivalent Growth (%)	-2,732.98	-58.25	182.17	33.63	8.74
Total Debt/ CFO (x)	20.28	7.40	6.12	-71.06	3.53

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	8.82	20.31	28.95	5.07	31.48
Net Cash used in Investing Activities	-26.82	-14.90	-18.43	-22.08	-13.43
Net Cash flow from Financing Activities	-11.76	-7.83	-7.71	17.43	-18.13
Net Cash Flow	-28.45	-2.42	2.81	0.42	-0.08
Closing Cash & Cash Equivalent	-27.59	1.64	4.04	1.23	0.81
Closing Cash & Cash Equivalent Growth (%)	-1,782.64	-59.39	228.96	51.26	-8.93
Total Debt/ CFO (x)	17.44	7.12	4.62	24.70	3.11

All figures in Rs Cr, unless mentioned otherwise

Insights

Decrease in Cash from Investing
Company has used Rs 9.85 cr for investing activities which is an YoY decrease of 33.95%. (Source: Consolidated Financials)

View Details

Ratios

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	7.68	9.32	10.66	4.03	9.57
Return on Capital Employed (%)	18.01	18.92	20.86	16.30	20.64
Return on Assets (%)	1.68	2.14	2.31	0.82	2.15
Interest Coverage Ratio (x)	2.01	1.88	2.25	2.14	2.75
Asset Turnover Ratio (x)	0.88	0.93	1.07	1.06	1.12
Price to Earnings (x)	15.15	18.38	19.53	40.98	28.57
Price to Book (x)	1.16	1.71	2.08	1.65	2.73
EV/EBITDA (x)	7.44	8.65	7.87	8.76	8.81
EBITDA Margin (%)	10.85	10.47	10.13	8.56	10.18

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	6.48	7.89	9.72	6.37	9.82
Return on Capital Employed (%)	15.68	16.46	17.97	15.27	17.95
Return on Assets (%)	1.72	2.22	2.84	1.76	2.96
Interest Coverage Ratio (x)	2.04	1.91	2.35	2.32	2.86
Asset Turnover Ratio (x)	0.84	0.85	0.95	0.95	1.02
Price to Earnings (x)	14.18	17.01	14.04	17.15	18.66
Price to Book (x)	0.92	1.34	1.37	1.09	1.83
EV/EBITDA (x)	7.08	8.35	7.40	7.91	8.51
EBITDA Margin (%)	11.01	10.65	10.57	9.29	10.59

Found Financials useful?

5 Days	14 Days	28 Days
-	-	-

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Bal Pharma	22.00	1.68	7.68	18.01	1.68	0.90	7.30	2.02	3.95	1.05	1.94	20.28
Aarey Drugs	52.42	1.58	2.63	6.84	1.33	4.25	2.20	0.84	1.39	1.81	0.33	4.93
Brooks Labs	7.99	1.60	20.04	5.25	16.59	10.96	7.74	6.77	8.35	1.72	0.06	0.78
Natural Capsule	-7.23	0.71	-7.70	-5.82	-4.02	2.96	-9.06	-13.17	-23.84	1.03	0.52	10.47
Alpa Labs	10.03	0.77	7.58	8.94	5.83	5.85	16.02	13.35	6.71	4.01	0.01	0.24
Add More

Annual Ratios (%)

Choose from Peers

Krebs Biochem
Par Drugs & Chemical
Vaishali Pharma
Biofil Chem
Vivimed Labs

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Bal Pharma Stock Performance	-1.10	9.98	11.91	11.56	-12.48	2.33	-9.93
Aarey Drugs Stock Performance	2.09	-8.43	-5.18	6.47	56.94	198.57	0.00
Brooks Labs Stock Performance	-1.95	38.92	4.12	-10.46	-51.13	6.94	-30.61
Natural Capsule Stock Performance	1.35	3.36	0.26	1.94	-19.00	0.00	0.00
Alpa Labs Stock Performance	0.37	-0.13	-0.99	1.79	-36.35	15.83	20.55
Add More

Category	No. of Shares	Percentage
Promoters	80,97,182	50.86 %
Pledge	0	0.00 %
FII	21,566	0.14 %
Others	78,02,124	49.00 %

Category	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Promoters	50.86	50.86	50.86	50.86
Pledge	0.00	0.00	0.00	0.00
FII	0.14	0.14	0.23	0.15
DII	0.00	0.00	0.00	0.00
Mutual Funds	0.00	0.00	0.00	0.00
Others	49.00	49.00	48.91	48.99

Mutual Funds Ownership

No Data Available

Corporate Actions

Recent
Final
12%
May 27, 2026
Board Meeting
Audited Results, Final Dividend & ESOP
May 18, 2026
Board Meeting
Quarterly Results
Feb 03, 2026

Board Meetings

Announced on	Meeting on
May 18, 2026	May 27, 2026
Audited Results, Final Dividend & ESOP
Feb 03, 2026	Feb 11, 2026
Quarterly Results
Nov 04, 2025	Nov 12, 2025
Quarterly Results
Jul 29, 2025	Aug 11, 2025
Quarterly Results, ESOP & A.G.M.
May 15, 2025	May 29, 2025
Audited Results & Dividend

Dividends
Announced on Ex-Date Dividend%
May 29, 2025 Sep 18, 2025 12%
May 28, 2024 Sep 18, 2024 12%
May 29, 2023 Sep 18, 2023 10%
May 30, 2022 Sep 13, 2022 10%
May 27, 2026 - 12%
Bonus
No Data Available
Splits
No Data Available
Rights
Announced on Ex-Date
Aug 03, 2004 Apr 07, 2005
Rights ratio: 3 share for every 5 held at a price of Rs 30.0

Announced on	Ex-Date	Dividend%
May 29, 2025	Sep 18, 2025	12%
May 28, 2024	Sep 18, 2024	12%
May 29, 2023	Sep 18, 2023	10%
May 30, 2022	Sep 13, 2022	10%
May 27, 2026	-	12%

Announced on	Ex-Date
Aug 03, 2004	Apr 07, 2005
Rights ratio: 3 share for every 5 held at a price of Rs 30.0

AGM/EGM Meetings

Announced on	Meeting on
Jan 08, 2026	Feb 10, 2026
-
Sep 10, 2025	Sep 25, 2025
Book closure from Sep 19, 2025 to Sep 25, 2025
Jun 30, 2025	Aug 01, 2025
-
Aug 14, 2024	Sep 25, 2024
Rs.1.2000 per share(12%)Final Dividend & A.G.M.
Nov 20, 2023	Dec 21, 2023
-

About Bal Pharma

Bal Pharma Ltd., incorporated in the year 1987, is a Small Cap company (having a market cap of Rs 138.24 Crore) operating in Pharmaceuticals sector.

Bal Pharma Ltd. key Products/Revenue Segments include Formulations, API, Other Operating Revenue, Scrap for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 83.84 Crore, down 4.75 % from last quarter Total Income of Rs 88.02 Crore and up 1.06 % from last year same quarter Total Income of Rs 82.96 Crore. Company has reported net profit after tax of Rs 3.60 Crore in latest quarter.

The company’s top management includes Mr.Shailesh D Siroya, Mr.Himesh Virupakshaya, Mr.Ravindrakumar Kothari, Mr.H S Venkatesh, Mr.Jatish Sheth, Ms.Nicloa Neeladri, Mr.D V Bharath Bhushan, Mr.Abdul Basith. Company has SSJNB & Co. as its auditors. As on 31-03-2026, the company has a total of 1.59 Crore shares outstanding.

Bal Pharma Share Price Today is Rs. 86.83. On previous day, the Bal Pharma Share Price (NSE) closed at Rs. 87.79, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 50.86% of the stake in Bal Pharma shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Bal Pharma stocks was 0.14% as compared to 0.14% in Dec 2025 with decrease of 0.0%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 0.0% as compared to 0.0% in Dec 2025 with null of 0.0%. Out of the total DII holdings in Bal Pharma shares 0.0% was held by mutual funds. The rest including public held is 0.0%. Bal Pharma stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Bal Pharma Dividend: Ever since 1987, Bal Pharma dividends has been paid out around 24 times. As on 19 Jun, 2026, 03:40 PM IST, The overall dividend yield for Bal Pharma stands at 1.37%. The last dividend paid was on September 18, 2025 (Rs. 1.2). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 3.95.

Bal Pharma Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 83.84 Cr. of sales and 4.75% of quarterly net loss, there have been multiple ups and downs in the Bal Pharma stock prices in the past few weeks. For example, Bal Pharma stock price on 12th of June 2026 was around Rs. 86.19. Bal Pharma share price now stands at an average of Rs. 86.83. Judging by last week's performance, stock is in up trend.

Bal Pharma has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Bal Pharma share.

Historical Prices and Performance:
Bal Pharma, incorporated in 1987 is a Small Cap company (with a market cap of Rs. 138.24) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by Bal Pharma stock was 7.68%, 9.32%, 10.66%, 4.03% and 9.57% respectively.
The Bal Pharma share gave a 3 year return of -2.22% as compared to Nifty 50 which gave a return of 28.03%.
Bal Pharma announced 12.0% final dividend on September 18, 2025.

Key Metrics:
PE Ratio of Bal Pharma is 22.24
Prices/Sales Ratio of Bal Pharma is 0.31
Price/Book Ratio of Bal Pharma is 1.7

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Bal Pharma, major competitors and peers include Aarey Drugs, Brooks Labs, Natural Capsule and Alpa Labs. As of Dec 2025, the dividend yield of Bal Pharma stands at 1.37% while Aarey Drugs, Brooks Labs, Natural Capsule and Alpa Labs stand at 0.0%, 0.0%, 0.0% and 0.0% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 22.24 and 1.7 respectively.

Leadership of Bal Pharma :
Abdul Basith is Co. Secretary & Compl. Officer
D V Bharath Bhushan is Chief Financial Officer
Shailesh D Siroya is Managing Director
Himesh Virupakshaya is Executive Director
Ravindrakumar Kothari is Non Executive Director
Jatish Sheth is Independent Director
Nicloa Neeladri is Independent Director
H S Venkatesh is Independent Director

Industry

Pharma - Indian

Key Indices Listed On

-

Address

# 21 & 22,Bommasandra Industrial Area,Bengaluru, Karnataka - 560099

Contact

info@balpharma.com

http://www.balpharma.com

PE Ratio(x)	22.00
EPS - TTM(₹)	3.95
MCap(₹ Cr.)	138.24
MCap Rank	110
PB Ratio(x)	1.70
Div Yield(%)	1.38
Face Value(₹)	10.00
52W High(₹)	104.50
52W Low(₹)	60.00
MCap/Sales	0.31
Beta(1 Month)	0.39
BV/Share(₹)	51.66

PE Ratio(x)	22.04
EPS - TTM(₹)	3.95
MCap(₹ Cr.)	138.51
MCap Rank	132
PB Ratio(x)	1.72
Div Yield(%)	1.38
Face Value(₹)	10.00
52W High(₹)	112.97
52W Low(₹)	59.69
MCap/Sales	0.31
Beta(1 Month)	-0.10
BV/Share(₹)	51.66

1 Day	-1.1%
1 Month	10.91%
3 Months	27.99%
1 Year	-12.01%
3 Years	-2.22%
5 Years	-10.58%

1 Day	-2.07%
1 Month	12.81%
3 Months	28.7%
1 Year	-11.58%
3 Years	-2.73%
5 Years	-10.4%

R1	-	Pivot -	S1	-
R2	-		S2	-
R3	-		S3	-

Bal Pharma Share Price

Key Metrics